151 related articles for article (PubMed ID: 14638721)
1. Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in herpetic stromal keratitis.
Wasmuth S; Bauer D; Yang Y; Steuhl KP; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5228-34. PubMed ID: 14638721
[TBL] [Abstract][Full Text] [Related]
2. Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.
Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):443-51. PubMed ID: 18030487
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal treatment with antisense oligonucleotides targeting tumor necrosis factor-α in murine herpes simplex virus type 1 retinitis.
Grajewski RS; Li J; Wasmuth S; Hennig M; Bauer D; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):231-8. PubMed ID: 22072377
[TBL] [Abstract][Full Text] [Related]
4. Subconjunctival antisense oligonucleotides targeting TNF-alpha influence immunopathology and viral replication in murine HSV-1 retinitis.
Li J; Wasmuth S; Bauer D; Baehler H; Hennig M; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1265-73. PubMed ID: 18491128
[TBL] [Abstract][Full Text] [Related]
5. Influence of antisense oligonucleotides targeting tumor necrosis factor-alpha on experimental herpetic-induced chorioretinitis of mouse eye.
Mei H; Xing Y; Yang J; Wang A; Xu Y; Heiligenhaus A
Pathobiology; 2009; 76(1):45-50. PubMed ID: 19188750
[TBL] [Abstract][Full Text] [Related]
6. [Do antisense oligonucleotides improve viral immunopathology?].
Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
Ophthalmologe; 2005 Mar; 102(3):272-8. PubMed ID: 15340755
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
[TBL] [Abstract][Full Text] [Related]
8. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis.
Keadle TL; Usui N; Laycock KA; Miller JK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):96-102. PubMed ID: 10634607
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
[TBL] [Abstract][Full Text] [Related]
10. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis.
Shirane J; Nakayama T; Nagakubo D; Izawa D; Hieshima K; Shimomura Y; Yoshie O
Curr Eye Res; 2004 May; 28(5):297-306. PubMed ID: 15287366
[TBL] [Abstract][Full Text] [Related]
11. Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice.
Yin J; Huang Z; Xia Y; Ma F; Zhang LJ; Ma HH; Li Wang L
Mol Vis; 2009 Jun; 15():1252-9. PubMed ID: 19547717
[TBL] [Abstract][Full Text] [Related]
12. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.
Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156
[TBL] [Abstract][Full Text] [Related]
13. A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis.
Xia L; Zhang S; Zhou J; Li Y
Mol Vis; 2010 Oct; 16():2071-83. PubMed ID: 21042564
[TBL] [Abstract][Full Text] [Related]
14. [Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis].
Xia LK; Zhang JS; Chen XL; Wang AY
Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):403-8. PubMed ID: 15938803
[TBL] [Abstract][Full Text] [Related]
15. Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.
Heiligenhaus A; Li H; Schmitz A; Wasmuth S; Bauer D
Clin Exp Immunol; 2005 Oct; 142(1):180-7. PubMed ID: 16178874
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.
Bauer D; Schmitz A; Van Rooijen N; Steuhl KP; Heiligenhaus A
Immunology; 2002 Sep; 107(1):118-28. PubMed ID: 12225370
[TBL] [Abstract][Full Text] [Related]
17. Blockade of IL-27 signaling ameliorates herpes stromal keratitis with upregulated CD4
Xia L; Tan T; Li Y; Zhong Q; Shi M
Indian J Ophthalmol; 2019 Nov; 67(11):1821-1828. PubMed ID: 31638041
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
Xia L; Zhang S; Cao Z; Hu Y; Yang H; Wang D
Microbes Infect; 2013 Feb; 15(2):126-39. PubMed ID: 23159245
[TBL] [Abstract][Full Text] [Related]
19. Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.
Inoue T; Inoue Y; Hayashi K; Yoshida A; Nishida K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
Cornea; 2002 Jan; 21(1):106-10. PubMed ID: 11805518
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.
Komatsu K; Miyazaki D; Morohoshi K; Kuo CH; Kakimaru-Hasegawa A; Komatsu N; Namba S; Haino M; Matsushima K; Inoue Y
Curr Eye Res; 2008 Sep; 33(9):736-49. PubMed ID: 18798077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
